<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Knee Surg Sports Traumatol Arthrosc</journal-id><journal-id journal-id-type="iso-abbrev">Knee Surg Sports Traumatol Arthrosc</journal-id><journal-title-group><journal-title>Knee Surgery, Sports Traumatology, Arthroscopy</journal-title></journal-title-group><issn pub-type="ppub">0942-2056</issn><issn pub-type="epub">1433-7347</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28939947</article-id><article-id pub-id-type="pmc">5794842</article-id><article-id pub-id-type="publisher-id">4725</article-id><article-id pub-id-type="doi">10.1007/s00167-017-4725-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Knee</subject></subj-group></article-categories><title-group><article-title>Similar cost-utility for double- and single-bundle techniques in ACL reconstruction</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6730-0572</contrib-id><name><surname>Sernert</surname><given-names>N.</given-names></name><address><email>ninni.sernert@vgregion.se</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hansson</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0624 0259</institution-id><institution-id institution-id-type="GRID">grid.459843.7</institution-id><institution>Department of Research and Development, </institution><institution>NU Hospital Group, </institution></institution-wrap>Trollh&#x000e4;ttan, Sweden </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9919 9582</institution-id><institution-id institution-id-type="GRID">grid.8761.8</institution-id><institution>Institute of Health and Care Sciences, </institution><institution>Sahlgrenska Academy, </institution></institution-wrap>Gothenburg, Sweden </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9919 9582</institution-id><institution-id institution-id-type="GRID">grid.8761.8</institution-id><institution>Institute of Clinical Sciences, </institution><institution>Gothenburg University, </institution></institution-wrap>Gothenburg, Sweden </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">000000009445082X</institution-id><institution-id institution-id-type="GRID">grid.1649.a</institution-id><institution>Department of Orthopaedics, </institution><institution>Sahlgrenska University Hospital, </institution></institution-wrap>Gothenburg, Sweden </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2018</year></pub-date><volume>26</volume><issue>2</issue><fpage>634</fpage><lpage>647</lpage><history><date date-type="received"><day>16</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">The aim was to estimate the cost-utility of the DB technique (<italic>n</italic>&#x000a0;=&#x000a0;53) compared with the SB (<italic>n</italic>&#x000a0;=&#x000a0;50) technique 2&#x000a0;years after ACL reconstruction.</p></sec><sec><title>Methods</title><p id="Par2">One hundred and five patients with an ACL injury were randomised to either the Double-bundle (DB) or the Single-bundle (SB) technique. One hundred and three patients (SBG <italic>n</italic>&#x000a0;=&#x000a0;50, DBG <italic>n</italic>&#x000a0;=&#x000a0;53) attended the 2-year follow-up examination. The mean age was 27.5 (8.4) years in the SBG and 30.1 (9.1) years in the DBG. The cost per quality-adjusted life years (QALYs) was used as the primary outcome. Direct costs were the cost of health care, in this case outpatient procedures. Indirect costs are costs related to reduce work ability for health reasons. The cost-utility analysis was measured in terms of QALY gained.</p></sec><sec><title>Results</title><p id="Par3">The groups were comparable in terms of clinical outcome. Operating room time was statistically significantly longer in the DBG (<italic>p</italic>&#x000a0;=&#x000a0;0.001), making the direct costs statistically significantly higher in the DBG (<italic>p</italic>&#x000a0;=&#x000a0;0.005). There was no significant difference in QALYs between groups. In the cost-effectiveness plane, the mean difference in costs and QALYs from the trial data using 1000 bootstrap replicates in order to visualise the uncertainty associated with the mean incremental cost-effectiveness ratio (ICER) estimate showed that the ICERs were spread out over all quadrants. The cost-effectiveness acceptability curve showed that there was a 50% probability of the DB being cost-effective at a threshold of Euro 50,000.</p></sec><sec><title>Conclusion</title><p id="Par4">The principal findings are that the DB is more expensive from a health-care perspective. This suggests that the physician may choose individualised treatment to match the patients&#x02019; expectations and requirements.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>HRQoL</kwd><kwd>QALY</kwd><kwd>ICER</kwd><kwd>Sensitivity analyses</kwd><kwd>ACL injury</kwd><kwd>Single- and double-bundle technique</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par24">Anterior cruciate ligament (ACL) rupture is an injury that is mostly related to sports, especially contact sports. However, the consequences affect not only the person&#x02019;s opportunity to continue with his/her sporting activities, perhaps resulting in a future career being ruined. It also affects the whole life, as several professions, such as heavy engineering work and construction work, require stable knees. At a time when health-care costs and the effectiveness of health treatments are major topics for discussion, every orthopaedic department has to consider the most cost-effective surgery in order to prioritise and provide the maximum additional effects per additional unit of resource consumed. According to the Swedish ACL Register, an injury frequency of approximately 80 per 100,000 inhabitants in Sweden would mean that some 5800 individuals suffer anterior cruciate ligament injuries every year and that some 3500 undergo surgery [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par25">Finding the optimal surgical technique is of great interest to every anterior cruciate ligament (ACL) surgeon. In the last decade, the double-bundle (DB) technique was introduced by restoring both the antero-medial and postero-lateral bundles.</p><p id="Par26">The question of whether the DB technique is able to restore rotational instability to a higher degree compared with the single-bundle (SB) technique is still the subject of debate. The findings in recent systematic reviews are in favour of the DB technique in terms of rotational laxity and IKDC grade [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par27">However, the DB technique is also more demanding and time-consuming and requires two fixation devices, thereby increasing the cost of the whole procedure. According to a meta-analysis, treatment with the DB technique is in favour in terms of knee joint stability and knee joint function [<xref ref-type="bibr" rid="CR27">27</xref>] but, at least from a health-care perspective, more costly than the SB technique. This is in line with Paxton et al., who concluded that the double-bundle technique may be cost-effective in terms of IKDC grade [<xref ref-type="bibr" rid="CR33">33</xref>]. In 2009, Brophy et al. [<xref ref-type="bibr" rid="CR9">9</xref>] compared the cost of the SB and DB techniques and concluded that DB added considerable costs to the health-care system with small clinical benefits to patients. Comparing health-related quality of life, Nunez et al. [<xref ref-type="bibr" rid="CR31">31</xref>] reported no significant difference between the SB and DB techniques, but concluded that the SB technique was more cost-effective in terms of knee joint stability and knee joint function.</p><p id="Par28">Another aspect that should be considered when comparing the two techniques is whether the new technique could shorten sick leave&#x02014;in other words, whether the new technique will offer a more stable knee earlier in the rehabilitation process, resulting in a shorter period of sick leave and thereby reducing the societal costs [<xref ref-type="bibr" rid="CR18">18</xref>]. The social insurance system in Sweden is financed through social insurance contributions, and the individual has a legal right to compensation due to lost income (<ext-link ext-link-type="uri" xlink:href="http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Socialforsakringsbalk-201011_sfs-2010-110/">http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Socialforsakringsbalk-201011_sfs-2010-110/</ext-link>).</p><p id="Par29">The available knowledge could form the basis of a cost-utility analysis (CUA), where the expected benefits are related to the costs. The result of a CUA is presented as cost per quality-adjusted life year (QALY). The CUA result can be used by decision-makers when deciding which health-care interventions should be made available in collectively funded health-care systems [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par30">Clinical research often involves comparing the clinical outcome of the new and old technique. However, it is important to relate the efficacy of the new treatment to the costs [<xref ref-type="bibr" rid="CR10">10</xref>], and many studies evaluate the cost-effectiveness from a health-care perspective (only including costs of health care); in the present study a societal perspective was used, including all costs involved after an ACL reconstruction.</p><p id="Par31">The aim of the present study was to estimate the cost-utility of the DB technique when compared with the SB technique in patients after ACL reconstruction. The hypothesis was that the choice of surgical technique affects the cost-utility.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par32">Data for the economic evaluation were collected alongside a randomised controlled study comparing the DB and SB techniques in 105 patients with ACL injuries 2&#x000a0;years after surgery. A CUA was conducted based on a comparison of the two surgical techniques. Prevalence-based direct and indirect costs were calculated from a societal perspective and compared to quality-adjusted life years estimated using the Euro QoL group five dimensions questionnaire for health-related quality of life (EQ-5D).</p><sec id="Sec3"><title>Design</title><p id="Par33">The study was conducted between 2008 and 2009 at two different hospitals in the western part of Sweden (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Patient-specific resources used and preference-based health status data were collected on an individual basis. A complete description of the study design and results of the clinical intervention have been published previously [<xref ref-type="bibr" rid="CR1">1</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Flow chart according to consort of included patients. Only patients with complete data on costs and effects (utility) (baseline and at three months) were included in the CUA</p></caption><graphic xlink:href="167_2017_4725_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par34">The cost difference was calculated by subtracting the mean cost of DB from the mean cost of SB. The cost per quality-adjusted life year (QALYs) was used as the primary outcome. The difference in QALYs was calculated by subtracting the mean QALYs for DB from the mean QALYs for SB. The economic evaluation was performed from a societal perspective.</p></sec><sec id="Sec4"><title>Study cohort</title><p id="Par35">The inclusion criterion was unilateral ACL injury in subjects over 18&#x000a0;years of age. The exclusion criteria were posterior cruciate ligament injury, more than 1+ medial or lateral collateral ligament laxity after injury or major previous knee surgery. Patients who fulfilled the inclusion criterion were consecutively asked to participate in the study. The participants were randomised to either the DB or the SB technique using closed envelopes administered by the same study coordinator for both hospitals.</p><p id="Par36">At the 2-year follow-up, 103 patients answered the EQ-5D questionnaire on health-related quality of life. The single-bundle group (SBG) consisted of 50 patients, 35 males and 15 females, while the double-bundle group (DBG) consisted of 53 patients, 35 males and 18 females. The mean age in the SBG was 27.5 (8.4) years, whereas it was 30.1 (9.1) years in the DBG. Of these, 98 patients, 49 in each group, attended a clinical examination 26 (3.0) months after the index operation (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Descriptive data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Double bundle (DB)</th><th align="left">Single bundle (SB)</th></tr></thead><tbody><tr><td align="left">Number of patients</td><td align="left">53</td><td align="left">50</td></tr><tr><td align="left">Gender male/female</td><td align="left">35/18</td><td align="left">35/15</td></tr><tr><td align="left">Age (years)</td><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">30.1 (9.1)</td><td align="left">27.5 (8.4)</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">29.0 (18-52)</td><td align="left">25 (18-51)</td></tr><tr><td align="left" colspan="3">Profession (%)</td></tr><tr><td align="left">&#x000a0;Student</td><td align="left">8 (15.1)</td><td align="left">12 (24)</td></tr><tr><td align="left">&#x000a0;Labourer</td><td align="left">27 (50.9)</td><td align="left">26 (52)</td></tr><tr><td align="left">&#x000a0;Clerical</td><td align="left">17 (32.1)</td><td align="left">9 (18)</td></tr><tr><td align="left">&#x000a0;Unemployed</td><td align="left"/><td align="left">2 (4)</td></tr><tr><td align="left">&#x000a0;Missing values</td><td align="left">1 (1.9)</td><td align="left">1 (2)</td></tr><tr><td align="left">Follow-up period [months; mean (SD)]</td><td align="left">25.5 (3.5)</td><td align="left">25.6 (2.3)</td></tr><tr><td align="left">Missing values</td><td align="left">1</td><td align="left">3</td></tr><tr><td align="left" colspan="3">Pre-injury Tegner activity level</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">7.3 (1.5)</td><td align="left">7.8 (1.3)</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">8 (5&#x02013;9)</td><td align="left">8 (3&#x02013;9)</td></tr><tr><td align="left">&#x000a0;Missing value</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">Time between the injury and index operation (months)</td><td align="left">9 (2&#x02013;240)</td><td align="left">10 (3&#x02013;240)</td></tr></tbody></table></table-wrap>
</p><p id="Par37">Two hospitals were involved in the present study; two experienced surgeons at each hospital performed all the ACL reconstructions using the same techniques. The learning curve was similar for all four surgeons. At Hospital A, 31 ACL reconstructions were performed (17 SB and 14 DB), and at Hospital B, 71 (33 SB and 38 DB) ACL reconstructions were performed.</p><p id="Par38">The overall clinical outcome presented in Ahld&#x000e9;n et al. [<xref ref-type="bibr" rid="CR1">1</xref>] was that the clinical assessments at follow-up revealed no significant differences between the DB and SB groups in terms of knee laxity measurements, range of motion, Lysholm knee scoring scale, Tegner activity scale, Knee Injury and Osteoarthritis and Outcome Score (KOOS) or functional tests. A significant improvement was seen in both groups compared with the pre-operative values in terms of most clinical assessments.</p></sec><sec id="Sec5"><title>Surgical method</title><p id="Par39">Standard antero-lateral and antero-medial portals were established. Associated intra-articular injuries, such as meniscal injuries and chondral lesions, were addressed at the time of the index operation.</p><p id="Par40">The surgical procedure for both the single- and double-bundle techniques is described in detail in the article by Ahld&#x000e9;n et al. [<xref ref-type="bibr" rid="CR1">1</xref>].</p><sec id="Sec6"><title>Post-operative procedure</title><p id="Par41">All patients had their surgery performed in an outpatient procedure, and none had to stay overnight because of complications.</p><p id="Par42">The general recommendation was to refrain from work for 6&#x000a0;weeks, but people with a physically light job were able to return to work after 2&#x000a0;weeks.</p></sec><sec id="Sec7"><title>Failure rates</title><p id="Par43">In the SBG, five patients underwent a re-operation within the 2-year follow-up period. The causes were pain (<italic>n</italic>&#x000a0;=&#x000a0;2), loose body (three times in the same patient) and meniscal injury (<italic>n</italic>&#x000a0;=&#x000a0;2). The corresponding number in the DBG was six patients, pain (<italic>n</italic>&#x000a0;=&#x000a0;1), meniscal and chondral injury (<italic>n</italic>&#x000a0;=&#x000a0;1), chondral injury (<italic>n</italic>&#x000a0;=&#x000a0;1), swelling (<italic>n</italic>&#x000a0;=&#x000a0;1), extension deficit (<italic>n</italic>&#x000a0;=&#x000a0;1) and arthroscopic evaluation (<italic>n</italic>&#x000a0;=&#x000a0;1) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par44">In the present study, post-operative appointments were made at the orthopaedic ward after 4&#x02013;6 weeks, seeing only the surgeon, and at 6 and 24&#x000a0;months after surgery, seeing both the surgeon and the physiotherapist. The clinical examination included range of motion (ROM), knee laxity measurements, functional tests commonly used to evaluate ACL-reconstructed patients, as well as radiographic examination. The routine is one post-operative visit to the surgeon after 4&#x02013;6 weeks and one to the physiotherapist after 6 months, but, as these patients were included in a randomised clinical trial study (RCT) comparing the two surgical methods, visits to the surgeon at six and 24&#x000a0;months were included, as well as the X-ray examination.</p></sec></sec><sec id="Sec8"><title>Post-operative rehabilitation programme</title><p id="Par45">A referral was given to the patients when leaving the hospital with the recommendation to contact their local physiotherapist and start rehabilitation seven to 10&#x000a0;days post-operatively [<xref ref-type="bibr" rid="CR1">1</xref>]. All the patients were rehabilitated according to the same guidelines.</p><sec id="Sec9"><title>Data extraction</title><p id="Par46">All patient reports, as well as surgical reports, were reviewed by two persons independently. Disagreement or uncertainty between two reviewers was resolved by consensus or after discussion with a third party, one of the surgeons.</p></sec></sec><sec id="Sec10"><title>Outcome measures</title><sec id="Sec11"><title>Health-related quality of life and quality-adjusted life years</title><sec id="Sec12"><title>EQ-5D</title><p id="Par47">The EQ-5D is a generic instrument for measuring overall health-related quality of life based on five dimensions (mobility, self-care, usual activities, pain/discomfort and depression/anxiety) and including three levels (none, moderate and severe problems) of answers and a rating scale. In the present study, the UK tariff values of scale between &#x02212;0.59 and 1 have been used. These social tariff values (elicited health state valuations from a representative sample of the UK health population) have previously been published [<xref ref-type="bibr" rid="CR12">12</xref>]. A summary index between 1 (full health), 0 (death) and values below 0 corresponding to worse than death has been calculated [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. A difference of 0.07 or more is regarded as clinically relevant [<xref ref-type="bibr" rid="CR39">39</xref>]. It was intended to be used for economic analysis (cost-utility analysis) and to make it possible to calculate the cost per QALY [<xref ref-type="bibr" rid="CR8">8</xref>]. Brazier et al. [<xref ref-type="bibr" rid="CR6">6</xref>] evaluated the EQ-5D in a group of patients with osteoarthritis of the knee and concluded that it could be used for economic evaluations of surgery.</p></sec></sec><sec id="Sec13"><title>QALY</title><p id="Par48">The quality of life weighting was then used to calculate QALYs. This measurement combines years of life with quality of life, so that the QALY, as a result of a treatment, can consist of increasing life expectancy and/or increased quality of life. QALY calculations (here using the EQ-5D) were made at individual level, reflecting the change from baseline to 2 years, assuming a linear change in QoL between the two measurements. QALY was calculated by using the area-under-the-curve approach.<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{QALY}} = \left( {\left( {{\text{EQ5D baseline }} + {\text{EQ5D }}2 {\text{years}}} \right)/2} \right) \times 2$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mtext>QALY</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mrow><mml:mtext>EQ5D baseline</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext>EQ5D</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mn>2</mml:mn><mml:mtext>years</mml:mtext></mml:mrow></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mo>&#x000d7;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math><graphic xlink:href="167_2017_4725_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p></sec></sec><sec id="Sec14"><title>Costs</title><p id="Par49">The cost in the current study consisted of direct and indirect costs (production loss). The direct costs were calculated from resources used in specialised outpatient care. These costs included all fixed costs, i.e. administration and other overhead costs, staff salaries and accommodation at recovery, as well as individual costs, such as examination, surgery (operating room (OpR), anaesthesia and material), post-operative visits, rehabilitation, laboratory tests or imaging. All costs were collected from the hospitals&#x02019; administrative records registered at individual level (e.g. hospitalisation), including fixed cost for the hospital stay and specific resources used during the treatment.</p><p id="Par50">The indirect costs are costs related to reduce work ability for health reasons. The human capital method was used in this study, estimating the potential production loss, based on the assumption that earnings reflect productivity [<xref ref-type="bibr" rid="CR13">13</xref>]. Using this method, the daily production loss on an individual basis was calculated and consisted of each individual&#x000b4;s number of days of sick leave, obtained from the National Social Insurance Board&#x02019;s (NSIB) central register (<ext-link ext-link-type="uri" xlink:href="http://www.forsakringskassan.se/privatpers">http://www.forsakringskassan.se/privatpers</ext-link>). All sick leave periods longer than 14&#x000a0;days and all disability pension payments are administered and registered by the NSIB. Statistics Sweden (<ext-link ext-link-type="uri" xlink:href="http://www.scb.se/Pages/List____250619.aspx">http://www.scb.se/Pages/List____250619.aspx</ext-link>) supplied the information relating to the national mean monthly salary for males and females presented for defined professions. As 15% and 24%, respectively, were students, the imputation of missing data for indirect costs was performed. Furthermore, the average salary (for defined professions among the study participants) from Statistics Sweden (<ext-link ext-link-type="uri" xlink:href="http://www.scb.se">http://www.scb.se</ext-link>) and payroll taxes (SEK 1334 per day of absence) were used to calculate the cost of productivity losses.</p><p id="Par51">Other costs associated with cruciate ligament damage, such as travelling to and from treatment, are not valued.</p><p id="Par52">All the costs were obtained and analysed retrospectively. The costs are presented in euros, using the 2010 average exchange rate (Euro 1&#x000a0;=&#x000a0;SEK 9.55).</p><sec id="Sec15"><title>Cost-utility analysis</title><p id="Par53">Cost-utility analysis (CUA) refers to a particular form of cost-effectiveness analysis where the outcome is measured in terms of QALY gained. This can be compared with the mean total cost (direct&#x000a0;+&#x000a0;indirect costs) of the programme to determine the cost per QALY gained.</p><p id="Par54">In this study, both QALY and costs are discounted by 3%.<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Incremental cost - effectiveness ratio }}\left( {\text{ICER}} \right) = \frac{{\Delta {\text{Cost(Cost}}_{\text{DBG}} - {\text{Cost}}_{\text{SBG}} )}}{{\Delta {\text{Effect }}\left( {{\text{QALY}}_{\text{DBG}} {-}{\text{QALY}}_{\text{SBG}} } \right)}}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mrow><mml:mtext>Incremental cost - effectiveness ratio</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mtext>ICER</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:msub><mml:mtext>Cost(Cost</mml:mtext><mml:mtext>DBG</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>Cost</mml:mtext><mml:mtext>SBG</mml:mtext></mml:msub><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mrow><mml:mtext>Effect</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mtext>QALY</mml:mtext><mml:mtext>DBG</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>QALY</mml:mtext><mml:mtext>SBG</mml:mtext></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="167_2017_4725_Article_Equb.gif" position="anchor"/></alternatives></disp-formula>
</p><p id="Par55">The ICER can be interpreted as the extra cost of obtaining one extra QALY and allows comparisons between interventions in all areas of health care, not necessarily comparable programmes [<xref ref-type="bibr" rid="CR10">10</xref>]. The results of the analysis are able to demonstrate whether the DB technique yields higher or reduced costs, reduced or improved utility in comparison with the SB technique and are presented in a so-called cost-effectiveness plane [<xref ref-type="bibr" rid="CR13">13</xref>].</p></sec><sec id="Sec16"><title>ICER uncertainty</title><p id="Par56">The cost-effectiveness plane was used to visualise the uncertainty surrounding the mean ICER point estimate. The plane displays the incremental costs on the <italic>y</italic>-axis and the incremental effects on the x-axis and is divided into four quadrants: north-east (NE), south-east (SE), south-west (SW) and north-west (NW) [<xref ref-type="bibr" rid="CR15">15</xref>]. If the ICERs are plotted in the NE quadrant, the DB technique yields higher costs and an improved effect and a willingness-to-pay (WTP) threshold would therefore be necessary, if the DB technique were implemented. Conversely, if ICERs are plotted in the SE quadrant, the DB technique both saves costs and has an improved effect; the DB technique is therefore the dominant strategy. If the ICERs are located in the SW quadrant, the DB technique reduces costs, but the effect decreases. Finally, if the ICERs are placed in the NW quadrant, the DB technique is both more expensive and reduces the effect, which explains why the existing treatment, the SB technique, clearly dominates.</p><p id="Par57">The cost-effectiveness acceptability curve (CEAC) is constructed so that it shows the proportion of simulations that are deemed cost-effective, given different threshold values for cost-effectiveness. It is the proportion of simulations to the right of a budget line with the slope corresponding to the threshold value in the figures. The CEAC illustrates the probability that the DB technique is cost-effective compared with the SB technique at different willingness-to-pay thresholds [<xref ref-type="bibr" rid="CR13">13</xref>]. In this analysis, the maximum willingness to pay was set at a level of Euro 50,000 (SEK 500,000), based on the Swedish National Board of Health and Welfare (<ext-link ext-link-type="uri" xlink:href="https://www.socialstyrelsen.se/SiteCollectionDocuments/metodbeskrivning-nationella-riktlinjer.pdf">https://www.socialstyrelsen.se/SiteCollectionDocuments/metodbeskrivning-nationella-riktlinjer.pdf</ext-link>).</p></sec><sec id="Sec17"><title>Sensitivity analysis</title><p id="Par58">To assess the strength of the result, an average salary from Statistics Sweden (<ext-link ext-link-type="uri" xlink:href="http://www.scb.se">http://www.scb.se</ext-link>) and payroll taxes were used to estimate the cost of productivity loss (SEK 1400 (=Euro 147) per day of absence).</p><p id="Par59">As a sensitivity analysis, both costs and effects are discounted at 5 and 0% (no discount) and costs are discounted at 3%, but no discount is made for effects. A health-care perspective using the direct costs is also presented.</p></sec></sec><sec id="Sec18"><title>Statistical analysis</title><p id="Par60">Sample size calculation was based on the pivot shift test with one degree of difference, a power of 0.85 and a level of significance of 0.05, which gives 38 patients in each group.</p><p id="Par61">Mean (SD) and median (range) values are presented when applicable. For comparisons of dichotomous variables between the groups, the Chi-square test was used. In terms of comparison between the groups of continuous variables, a <italic>t</italic> test was used, while for discrete variables the Mann&#x02013;Whitney <italic>U</italic> test was used. A <italic>p</italic>-value of &#x02264;&#x000a0;0.05 was considered statistically significant. Effect size was calculated as the difference between pre-operative values and post-operative values.</p><p id="Par62">By using bootstrapping, we wanted to assess the statistical uncertainty associated with the ICER. We simulate new ICERs as if they were single mean estimates from the trial by building up an empirical sampling distribution (based on the original data) in order to make inferences about the ICER. The number of units is the same as the number of patients in the analysis and the CI is based on 1000 such samplings. The bootstrapping analysis was performed using the SAS 9.2 computer program, Cary, NC.</p></sec><sec id="Sec19"><title>Ethics</title><p id="Par63">Eligible patients were informed about the study and gave their signed informed consent. The Regional Ethical Review Boards at the University of Gothenburg approved the study, (2011-07-25) Dnr 162-11, and permission was also obtained from the heads of the individual clinics.</p></sec></sec><sec id="Sec20"><title>Results</title><p id="Par64">Pre-operatively, the groups were comparable in terms of demographic data (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par65">Descriptive data relating to the total intervention procedure are presented in Tables&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>. The sensitivity analysis is presented in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Clinical resource use and days of sick leave</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Double bundle (DB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;53</th><th align="left">Single bundle (SB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;50</th><th align="left">
<italic>P</italic> value<break/>SB versus DB</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left" colspan="5">Operating room (OpR) time</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">68.4 (12.7)</td><td align="left">56.8 (16.5)</td><td align="left" rowspan="2">
<bold>0.001</bold>
</td><td align="left" rowspan="2">VGR medical record</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">70 (41&#x02013;92)</td><td align="left">55.5 (26&#x02013;90)</td></tr><tr><td align="left" colspan="5">Number of post-op visits to the surgeon</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">3.3 (0.9)</td><td align="left">3.4 (0.9)</td><td align="left" rowspan="2">n.s.</td><td align="left" rowspan="2">VGR medical record</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">3 (2&#x02013;7)</td><td align="left">3 (2&#x02013;6)</td></tr><tr><td align="left" colspan="5">Consulting phone calls to surgeons</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">0.43 (1.22)</td><td align="left">0.34 (0.69)</td><td align="left" rowspan="2">n.s.</td><td align="left" rowspan="2">VGR medical record</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">0 (0&#x02013;8)</td><td align="left">0 (0&#x02013;3)</td></tr><tr><td align="left" colspan="5">Consulting phone calls to nurse on the orthopaedic ward</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">0.08 (0.27)</td><td align="left">0.20 (0.73)</td><td align="left" rowspan="2">n.s.</td><td align="left" rowspan="2">VGR medical record</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">0 (0&#x02013;1)</td><td align="left">0 (0&#x02013;4)</td></tr><tr><td align="left" colspan="5">Associated injuries addressed at the time of the index operation or during the follow-up period</td></tr><tr><td align="left">&#x000a0;Meniscal (medial and/or lateral)</td><td align="left">15 (28%)</td><td align="left">18 (36%)</td><td align="left" rowspan="4">n.s.</td><td align="left" rowspan="4">VGR medical record</td></tr><tr><td align="left">&#x000a0;Meniscal and chondral</td><td align="left">14 (26%)</td><td align="left">13 (26%)</td></tr><tr><td align="left">&#x000a0;Chondral</td><td align="left">6 (11%)</td><td align="left">7 (14%)</td></tr><tr><td align="left">&#x000a0;None</td><td align="left">18 (34%)</td><td align="left">12 (24%)</td></tr><tr><td align="left" colspan="5">Registered complications</td></tr><tr><td align="left">&#x000a0;None</td><td align="left">48 (90.6%)</td><td align="left">45 (90%)</td><td align="left" rowspan="7">n.s.</td><td align="left" rowspan="7">VGR medical record</td></tr><tr><td align="left">&#x000a0;Bleeding</td><td align="left">2 (3.8%)</td><td align="left">1 (2%)</td></tr><tr><td align="left">&#x000a0;Extension deficit</td><td align="left">1 (1.9%)</td><td align="left">&#x02013;</td></tr><tr><td align="left">&#x000a0;Fever</td><td align="left">1 (1.9%)</td><td align="left">1 (2%)</td></tr><tr><td align="left">&#x000a0;Infection</td><td align="left">&#x02013;</td><td align="left">1 (2%)</td></tr><tr><td align="left">&#x000a0;Locking</td><td align="left">1 (1.9%)</td><td align="left">1 (2%)</td></tr><tr><td align="left">&#x000a0;Pain/swelling</td><td align="left">&#x02013;</td><td align="left">1 (2%)</td></tr><tr><td align="left">Re-operations yes/no</td><td align="left">6/47</td><td align="left">5/45</td><td align="left" rowspan="4">n.s.</td><td align="left" rowspan="4">VGR medical record</td></tr><tr><td align="left">Meniscal/cartilage</td><td align="left">3 (6%)</td><td align="left">3 (6%)</td></tr><tr><td align="left">Loose bodies</td><td align="left"/><td align="left">1 (2%)</td></tr><tr><td align="left">Notchplasty</td><td align="left">1 (2%)</td><td align="left">1 (2%)</td></tr><tr><td align="left" colspan="5">Visits to physiotherapist</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">18.9 (20.7)</td><td align="left">19.8 (18.4)</td><td align="left" rowspan="2">n.s.</td><td align="left" rowspan="2">PT<sup>a</sup>
</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">13 (0-88)</td><td align="left">15.5 (0-68)</td></tr><tr><td align="left" colspan="5">Sick leave (total days)</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">64.6 (87.5)</td><td align="left">80.2 (82.5)</td><td align="left" rowspan="3">n.s.</td><td align="left" rowspan="3">N S I B</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">32.75 (5&#x02013;442)</td><td align="left">45.0 (5&#x02013;284)</td></tr><tr><td align="left">&#x000a0;Missing values</td><td align="left">9</td><td align="left">13</td></tr></tbody></table><table-wrap-foot><p>Bold value represent <italic>p</italic>-value of &#x02264;&#x000a0;0.05 was considered statistically significant</p><p>
<italic>VGR</italic> V&#x000e4;stra G&#x000f6;taland Region, Sweden, <italic>NSIB</italic> National Social Insurance Board</p><p>
<sup>a</sup> Personal contact with each physiotherapy department rehabilitating ACL injuries</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Mean cost per resource use variable and difference</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Mean cost per patient (Euro)/DB<break/>
<italic>n</italic>&#x000a0;=&#x000a0;53</th><th align="left">Mean cost per patient (Euro)/SB<break/>
<italic>n</italic>&#x000a0;=&#x000a0;50</th><th align="left">Difference in mean costs (Euro)</th><th align="left">
<italic>P</italic> value<break/>SB versus DB</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left" colspan="6">Costs OpR<sup>a</sup> surgery</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">846 (757)</td><td align="left">651 (633)</td><td char="." align="char">195</td><td align="left">
<bold>0.019</bold>
</td><td align="left">VGR</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">453 (185&#x02013;3258)</td><td align="left">351 (146&#x02013;3289)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Cost OpR<sup>a</sup> anaesthesia</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">1077 (653)</td><td align="left">794 (505)</td><td char="." align="char">283</td><td align="left">
<bold>0.041</bold>
</td><td align="left">VGR</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">1077 (194&#x02013;2064)</td><td align="left">794 (204&#x02013;1790)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Costs ReR<sup>b</sup>
</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">119 (33)</td><td align="left">113 (33)</td><td char="." align="char">6</td><td align="left">n.s.</td><td align="left">VGR</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">119 (78&#x02013;207)</td><td align="left">113 (61&#x02013;175)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Other costs<sup>c</sup>
</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">876 (16.1)</td><td align="left">892 (13.1)</td><td char="." align="char">16</td><td align="left">n.s.</td><td align="left">VGR</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">876 (851&#x02013;920)</td><td align="left">892 (869&#x02013;920)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Costs rehabilitation (PT)<sup>f</sup>
</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">1, 895 (2078)</td><td align="left">1980 (1839)</td><td char="." align="char">&#x02212;85</td><td align="left">n.s.</td><td align="left"/></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">1307 (0&#x02013;8818)</td><td align="left">1553 (0&#x02013;6814)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Total direct costs (sum)</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">4813 (2274)</td><td align="left">4430 (2334)</td><td char="." align="char">469</td><td align="left">n.s.</td><td align="left">VGR</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">4463 (1916&#x02013;11,002)</td><td align="left">3903 (1579&#x02013;10,738)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Monthly salary (Euro)</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">3025 (842)</td><td align="left">2785 (597)</td><td align="left"/><td align="left"/><td align="left">SCB</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">2796 (2095&#x02013;6387)</td><td align="left">2660 (2105&#x02013;5330)</td><td char="." align="char">240</td><td align="left">n.s</td><td align="left"/></tr><tr><td align="left">&#x000a0;Missing values</td><td align="left">9</td><td align="left">14</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Production loss<sup>d</sup> (Euro)</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">8145 (9373)</td><td align="left">9063 (7993)</td><td char="." align="char">&#x02212;918</td><td align="left">n.s.</td><td align="left">N S I B</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">5769 (459&#x02013;50,079)</td><td align="left">8632 (560&#x02013;33,480)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">Total costs (Euro)</td><td align="left">12,958</td><td align="left">13,493</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">Total costs discounted (3%)<sup>e</sup>
</td><td align="left">12,569</td><td align="left">13,088</td><td char="." align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">13,199 (9910)</td><td align="left">13,762 (8526)</td><td char="." align="char">&#x02212;563</td><td align="left">n.s.</td><td align="left"/></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">11,180 (3194&#x02013;55,476)</td><td align="left">11,823 (2588&#x02013;36,478)</td><td char="." align="char"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p>Bold value represent <italic>p</italic>-value of &#x02264; 0.05 was considered statistically significant</p><p>
<italic>DB</italic> double-bundle technique, <italic>SB</italic> single-bundle technique, <italic>VGR</italic> V&#x000e4;stra G&#x000f6;taland region, <italic>NSIB</italic> National Social Insurance Board, Sweden, <italic>SCB</italic> Statistics Sweden</p><p>
<sup>a</sup> Operating room, including cost of bundle, 260 euro (SBG) and 548 euro (DBG)</p><p>
<sup>b</sup> Recovery room</p><p>
<sup><bold>c</bold></sup> Other costs include an overall cost for peripheral costs such as post-operative visits, consulting time OpR. Anaesthesia. ReR and post-op visits</p><p>
<sup>d</sup> Monthly salary (SCB)&#x000a0;&#x000d7;&#x000a0;1.3142 (social contributions)/30&#x000a0;&#x000d7;&#x000a0;days of sick leave, based on imputed data</p><p>
<sup>e</sup> Sum of total direct costs&#x000a0;+&#x000a0;production loss</p><p>
<sup>f</sup> Physiotherapy</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Sensitivity analysis and production loss based on average of wages from Statistics Sweden</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Mean cost per patient (Euro)/DB<break/>
<italic>n</italic>&#x000a0;=&#x000a0;53</th><th align="left">Mean cost per patient (Euro)/SB<break/>
<italic>n</italic>&#x000a0;=&#x000a0;50</th><th align="left">Difference in mean costs (Euro)</th><th align="left">
<italic>P</italic> value<break/>SB versus DB</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left" colspan="6">Production loss<sup>c</sup>
</td></tr><tr><td align="left">&#x000a0;Mean (SD)<sup>a</sup>
</td><td align="left">8145 (9373)</td><td align="left">9063 (7993)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Mean (SD)<sup>b</sup>
</td><td align="left">9329 (11,666)</td><td align="left">10,944 (10,454)</td><td char="." align="char">&#x02212;1615</td><td align="left">n.s</td><td align="left">NSIB</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">7147 (733&#x02013;64,796)</td><td align="left">8632 (733&#x02013;41,634)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="6">Total costs discounted (3%)</td></tr><tr><td align="left">&#x000a0;Mean (SD)<sup>a</sup>
</td><td char="." align="char">12,569</td><td char="." align="char">13,088</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Mean (SD)<sup>b</sup>
</td><td align="left">13,718 (11,505)</td><td align="left">14,913 (10,295)</td><td char="." align="char">&#x02212;1195</td><td align="left">n.s</td><td align="left"/></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">10,484 (3128&#x02013;66,633)</td><td align="left">12,043 (2475&#x02013;42,275)</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p>
<italic>NSIB</italic> National Social Insurance Board, based on average of wages from Statistics Sweden</p><p>
<sup>a</sup>&#x000a0;Based on the average salary of included professions</p><p>
<sup>b</sup>&#x000a0;Based on average salary according to Statistics Sweden</p><p>
<sup>c</sup>&#x000a0;Direct and indirect costs</p></table-wrap-foot></table-wrap>
</p><p id="Par66">The groups were comparable pre-operatively and at follow-up in terms of HRQoL (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>EQ-5D and QALY</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Double bundle (DB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;53</th><th align="left">Single bundle (SB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;50</th><th align="left">
<italic>P</italic> value<break/>SB versus DB</th></tr></thead><tbody><tr><td align="left" colspan="4">EQ-5D pre-op</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">0.639 (0.29)</td><td align="left">0.639 (0.24)</td><td align="left">n.s.</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">0.727 (&#x02212;0.077 to 1.00)</td><td align="left">0.691 (0&#x02013;1.00)</td><td align="left"/></tr><tr><td align="left" colspan="4">EQ-5D 2 years Fp*</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">0.839 (0.22)</td><td align="left">0.849 (0.19)</td><td align="left">n.s.</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">0.848 (0.088&#x02013;1.00)</td><td align="left">0.822 (0.088&#x02013;1.00)</td><td align="left"/></tr><tr><td align="left">&#x000a0;Missing value</td><td char="." align="char">2</td><td char="." align="char">2</td><td align="left"/></tr><tr><td align="left">Difference between pre-op and 2 years</td><td align="left">0.201 (0.31)</td><td align="left">0.212 (0.27)</td><td align="left">n.s.</td></tr><tr><td align="left" colspan="4">QALY</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">1.48 (0.41)</td><td align="left">1.49 (0.34)</td><td align="left">n.s.</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">1.59 (0.29&#x02013;2.0)</td><td align="left">1.52 (0.12&#x02013;2.0)</td><td align="left"/></tr><tr><td align="left">&#x000a0;Missing values</td><td char="." align="char">2</td><td char="." align="char">2</td><td align="left"/></tr><tr><td align="left" colspan="4">QALY discounted 3%</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">1.43 (0.40)</td><td align="left">1.44 (0.33)</td><td align="left">n.s.</td></tr><tr><td align="left">&#x000a0;Median (range)</td><td align="left">1.54 (0.29&#x02013;1.94)</td><td align="left">1.48 (0.11&#x02013;1.94)</td><td align="left"/></tr><tr><td align="left">&#x000a0;Missing values</td><td char="." align="char">2</td><td char="." align="char">2</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>*&#x000a0;<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.001, comparison between pre-operative and 2-year follow-up values within the groups</p></table-wrap-foot></table-wrap>
</p><p id="Par67">The ICER points (based on the average salary for defined professions among the study participants) were distributed in each of the four quadrants, where 20.2% were located in the NW quadrant, 34.9% in the SW quadrant, 38.0% in the SE quadrant and 6.9% in the NE quadrant. In other words, the ICERS are spread out over all the quadrants (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>
<bold>a</bold> Incremental cost-effectiveness ratio (ICER) of DB versus SB for patients with ACL injury. The costs are based on the average salary of included professions. <bold>b</bold> The incremental cost-effectiveness ratio (ICER) of DB versus SB for patients with ACL injury. ICER based on average salary according to Statistics Sweden</p></caption><graphic xlink:href="167_2017_4725_Fig2_HTML" id="MO4"/></fig>
</p><p id="Par68">The CEAC (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) is based on the average salary for defined professions and means that there is a 50% probability of the DB technique being cost-effective at a willingness-to-pay threshold of Euro 50,000 with great uncertainty in the ICER estimates.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Cost-effectiveness acceptability curve (CEAC), based on average salary of included professions. The red dotted line shows that the maximum willingness to pay was set at a level of &#x020ac;50,000 (SEK 500,000) based on the Swedish National Board of Health Care</p></caption><graphic xlink:href="167_2017_4725_Fig3_HTML" id="MO5"/></fig>
</p><sec id="Sec21"><title>Sensitivity analysis</title><p id="Par69">The ICER point (based on average salary for defined professions) was distributed in each of the four quadrants, where 20.2% was located in the NW quadrant, 34.9% in the SW quadrant, 38.0% in the SE quadrant and 6.9% in the NE quadrant (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a).</p><p id="Par70">The CEAC (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) based on average salary for defined professions there is a 50 probability of DBG being cost-effective at a threshold of willingness to pay of Euro 53,000, however with a great uncertainty in the ICER estimates.</p><p id="Par71">The total mean cost for DBG and SBG, when using the average salary from Statistics Sweden, was Euro 13,718 and Euro 14,913, respectively (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>), which is slightly higher costs in comparison with the national mean monthly salary for males and females presented for defined professions (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The ICERs based on average salary (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b) showed that 40.6% was located in the SW, 40.1% in the SE, 4.3% in the NW and 15% in the NE quadrant. Here the CEAC showed that around 55 probability of DB being cost-effective at a willingness-to-pay threshold of Euro 53,000.</p><p id="Par72">The discount rate 0, 3 and 5% for costs and QALYs is presented in Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>.<table-wrap id="Tab6"><label>Table&#x000a0;6</label><caption><p>Sensitivity analysis and discount rate 0, 3 and 5% for costs and QALYs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Discount rate</th><th align="left">Double bundle (DB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;53</th><th align="left">Single bundle (SB)<break/>
<italic>n</italic>&#x000a0;=&#x000a0;50</th><th align="left">Difference</th><th align="left">Cost-effectiveness plane</th></tr></thead><tbody><tr><td align="left" colspan="5">
<italic>Societal perspective</italic>
</td></tr><tr><td align="left">0% total costs</td><td char="." align="char">12,958</td><td char="." align="char">13,439</td><td char="." align="char">&#x02212;481</td><td align="left" rowspan="2">Cheaper/worse</td></tr><tr><td align="left">0% QALY</td><td char="." align="char">1.48</td><td char="." align="char">1.49</td><td char="." align="char">&#x02212;0.01</td></tr><tr><td align="left">5% total costs</td><td char="." align="char">12,310</td><td char="." align="char">12,767</td><td char="." align="char">&#x02212;457</td><td align="left" rowspan="2">Cheaper/worse</td></tr><tr><td align="left">5% QALY</td><td char="." align="char">1.41</td><td char="." align="char">1.42</td><td char="." align="char">&#x02212;0.01</td></tr><tr><td align="left">3% total costs</td><td char="." align="char">12,569</td><td char="." align="char">13,088</td><td char="." align="char">&#x02212;519</td><td align="left" rowspan="2">Cheaper/worse</td></tr><tr><td align="left">0% QALY</td><td char="." align="char">1.48</td><td char="." align="char">1.49</td><td char="." align="char">&#x02212;0.01</td></tr><tr><td align="left" colspan="5">
<italic>Health-care perspective</italic>
</td></tr><tr><td align="left">3% direct costs</td><td align="left">4717</td><td char="." align="char">4297</td><td char="." align="char">420</td><td align="left" rowspan="2">More expensive/worse</td></tr><tr><td align="left">3% QALY</td><td char="." align="char">1.43</td><td char="." align="char">1.44</td><td char="." align="char">&#x02212;0.01</td></tr></tbody></table></table-wrap>
</p></sec></sec><sec id="Sec22"><title>Discussion</title><p id="Par73">The principal findings in the present study are that the double-bundle technique is more expensive, as it takes longer in the operating room and requires more materials (direct costs <italic>p</italic>&#x000a0;=&#x000a0;0.005), which means that the DB is more expensive from a health-care perspective. However, from a societal perspective there was no statistically significant difference between the groups receiving SBG and DBG, due to lower costs for production loss among patients in the DB group. This was confirmed when analysing both average salary for defined professions among the study participants and for national mean monthly salary (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a, b). There was no difference between the groups in terms of QALYs.</p><sec id="Sec23"><title>Single-bundle versus double-bundle technique</title><p id="Par74">In a recent systematic review by Mascarenhas et al. [<xref ref-type="bibr" rid="CR29">29</xref>] analysing nine meta-analyses, the conclusion was that the double-bundle technique provided better post-operative knee stability, as measured with the KT 1000 arthrometer and pivot shift. This is also in line with the present study [<xref ref-type="bibr" rid="CR1">1</xref>]. The 5-year follow-up of the present study has recently been published, and no statistical differences could be found between the groups in terms of clinical outcome or the presence of osteoarthritis [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par75">However, the development of OA may take longer than 5&#x000a0;years to be radiographically visible. From a societal perspective, the future costs may include the consequences of the development of OA, such as sick leave and the need for a total knee arthroplasty. Today, according to the Swedish ACL Register, the use of the DB technique accounted for fewer than 1% of all the operations performed in 2015 [<xref ref-type="bibr" rid="CR17">17</xref>]. The main reason from the health-care perspective for not implementing the DB technique is higher direct costs, with a clinical outcome comparable to that produced by the SB technique.</p><p id="Par76">In a meta-analysis, Li et al. [<xref ref-type="bibr" rid="CR28">28</xref>] pooled data from seven studies and found no evidence of a significant difference in complication rate between the single- and double-bundle techniques. This is in line with the present study. No complications were registered in 90% of the patients, both groups, respectively. The low complication rate is also seen in the post-operative visits and consulting phone calls to the surgeon or nurse on the orthopaedic ward within standard care. No re-ruptures or revision surgery was registered during the follow-up period in the present study [<xref ref-type="bibr" rid="CR1">1</xref>].</p></sec><sec id="Sec24"><title>Total costs</title><sec id="Sec25"><title>Direct costs</title><p id="Par77">Orthopaedics, especially sporting injuries, are often given as an explanation of the increased costs within the health-care system and orthopaedic surgeons have to justify their choice of procedure [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. These costs should be compared with the reduction in hospital stay or outpatient surgery and earlier, accelerated rehabilitation. This results in an improved functional outcome for the patient and hopefully a smaller burden on society [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par78">The cost of ACL reconstructions, as well as other orthopaedic sports medicine injuries, is part of the entire health-care system and is charged to the orthopaedic department, along with all the other orthopaedic diagnoses. Nwachukwu et al. [<xref ref-type="bibr" rid="CR32">32</xref>] evaluated the cost-effectiveness analyses in orthopaedic sports medicine literature and suggested that ACL reconstruction was cost-effective. On the other hand, a recent study published by Kiadiliri et al. [<xref ref-type="bibr" rid="CR26">26</xref>] found no statistically significant difference in economic value in terms of early ACL reconstruction compared with rehabilitation and ACL reconstruction when needed. They may improve the outcome, but at greater expense and with higher administrative costs, plus lapses in quality [<xref ref-type="bibr" rid="CR2">2</xref>]. An ACL injury is a serious knee injury, and it is more common in young athletes performing highly demanding sports. They are often very eager to have the &#x02018;best&#x02019; (=&#x000a0;newest) treatment, resulting in a rapid return to their previous level of sporting activity. At a time at which new technology and techniques are easily spread and popularised through social media, there is a need critically to evaluate not only the clinical results, but also the costs, before any implementation in clinical practice. Saltzman et al. conducted an economic analysis of ACL reconstruction comparing different surgical techniques, including the type of grafts, and concluded that the single-bundle technique offered greater economic value compared with the double-bundle technique. This is in line with Brophy et al. [<xref ref-type="bibr" rid="CR9">9</xref>] who concluded that the double-bundle technique should not be accepted as the new standard technique until evidence of improved clinical outcome is presented. On the other hand, only the study by Paxton et al. used cost-utility analysis and ICER, showing that the double-bundle technique is a cost-effective procedure [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. According to the ACL Register, in 2014, only 28 ACL reconstructions of 3430 were performed using the double-bundle technique [<xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec26"><title>Production loss (indirect costs)</title><p id="Par79">The total days of sick leave differed between the two groups, 80&#x000a0;days in the SBG and 65&#x000a0;days in the DBG, but this difference was not statistically significant. The median difference of 15&#x000a0;min in time in the operating room may not result in post-operative discomfort and longer sick leave (production loss). The difference in sick leave could reflect differences in occupation between the two groups, prolonging the return to work, irrespective of the type of reconstruction technique used. There were, for example, more self-employed people in the DBG (30 vs 14%), which could suggest a greater eagerness to resume work. The larger number of days off work in the SBG might, however, randomly also reflect the fact that working ability and sick leave are highly subjective measurements with a large impact on costs in a study like this [<xref ref-type="bibr" rid="CR21">21</xref>]. There are missing data on sick leave in 22 patients (13 in the SBG and nine in the DBG), and this might be due to unemployment, being student or being left out of the insurance system for other reasons. However, imputed data were used in the analysis. In this study, only post-operative sick leave periods longer than 14&#x000a0;days and all payments are included. The difference in health-care organisation and insurance system between countries must also be taken into account.</p><p id="Par80">In recent years, focusing on rehabilitation programmes and the criteria for knee function has been a topic of great interest, as the return to competitive sport is relatively low [<xref ref-type="bibr" rid="CR23">23</xref>]. However, the primary objective, after all, is to be able to return to work. Even though the individual has a legal right to compensation due to lost income through the Swedish social insurance system, this does not cover the whole loss of income. Heavy industrial workers and craftsmen have to regain full muscle strength, as well as health-related quality of life.</p><p id="Par81">The health-related quality of life result, as measured with the EQ-5D, was in line with data from the Swedish National ACL database, comparing the single-bundle and double-bundle technique [<xref ref-type="bibr" rid="CR4">4</xref>], but lower compared with the general Swedish population [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par82">As the DB trial was primarily designed to detect a difference of one degree in the pivot shift test, the number of enrolled subjects may have been too low to detect a difference in QALY during the trial period. The baseline analysis conducted prior to the CUA did not detect any statistically significant differences in baseline utility. Further, the collection of QALYs in the DB trial could have been improved, as the EQ-5D score was only measured at baseline and at the 2-year follow-up. In the light of the fact that patients after ACL reconstruction are not re-admitted to the hospital due to re-injury to the ACL, it was not necessary to include further EQ-5D score measurements in the trial and the follow-up period, as this would not have increased the accuracy of the results.</p></sec><sec id="Sec27"><title>QALY</title><p id="Par83">In the present study, the QALY for the single-bundle group and double-bundle group was 1.44 and 1.43, respectively. This means that there was no gain in QALYs for the DB group (&#x02212;0.01). Performing a cost-effectiveness comparison of different types of graft, Genuario et al. [<xref ref-type="bibr" rid="CR19">19</xref>] reported a QALY of between 0.904 and 0.912, while Farshad et al. [<xref ref-type="bibr" rid="CR14">14</xref>] compared conservative treatment with ACL reconstruction and reported a QALY of 0.66.</p><p id="Par84">The gain in QALY is also higher (0.212 and 0.201, respectively) compared with the cost-utility analysis conducted on the Multicentre Orthopedics Outcomes Network (MOON) database (0.18) [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par85">The cost-effectiveness plane, where the 1000 bootstrap replicates of the ICER were spread out of over the quadrants, demonstrated that the DB cost almost as much as the SB and had the same effect as the SB (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The sensitivity analysis revealed marginal/no differences between the discount rates of 0 and 5% for costs and QALYs. From a health-care perspective, the DB technique cannot be recommended. However, from the patients&#x02019; perspective, the physician should consider individual treatment based on who the patient is and what his/her expectations and requirements are [<xref ref-type="bibr" rid="CR25">25</xref>]. Other aspects to take into consideration are the preferences, experiences and skill of the orthopaedic surgeons when choosing the technique.</p></sec></sec><sec id="Sec28"><title>Strengths and limitations</title><p id="Par86">One strength of the present study is the randomised design and the follow-up rate of 98%. The clinical results are also in line with those in previous studies. It is common for the sample size of a trial to be based on the primary clinical outcome, and in this study, the sample size was calculated on the difference in pivot shift and not on differences in health-related quality of life. This is a major limitation, as, in a calculation based on the difference in sick leave or total costs, the power will be low. However, comparing costs, as in the present study, takes place alongside an analysis based on a clinical randomised trial. Moreover, the change in the EQ-5D over time is based on two measurement points (pre-operatively and at the 2-year follow-up), assuming a linear function using an area-under-the-curve approach. The first 2 weeks of sick leave are paid by the employer, while sick leave periods longer than 14&#x000a0;days are administered and registered by the NSIB. As the recommended period of sick leave after an ACL reconstruction is at least 6 weeks, the total costs including the employers&#x02019; contribution may have been higher, but the difference between groups would be the same. Another limitation is that the direct costs at a university hospital may have been higher than those at a county hospital. There was, however, no intention to compare the two hospitals. The fact that the cost analyses are dependent on the health-care cost and policy of the specific country, thereby limiting the external validity, must also be taken into consideration.</p></sec><sec id="Sec29"><title>Clinical perspective</title><p id="Par87">The results of the present study give the physician the possibility to choose an individualised treatment based on age, gender, symptoms and the size of the native ACL insertion site, but also have a detailed discussion with the patient relating to expectations and requirements [<xref ref-type="bibr" rid="CR25">25</xref>], such as rehabilitation intensity and demands relating to activity level, in terms of both sports activity level and work [<xref ref-type="bibr" rid="CR3">3</xref>]. In the long term, this will hopefully be more cost-effective for both the patient and society.</p></sec></sec><sec id="Sec30"><title>Conclusion</title><p id="Par88">The double-bundle technique is more expensive than the single-bundle technique, as it takes longer in the operating room and requires more materials. On the other hand, no difference was found in total costs, due to lower costs for production losses among patients in the DB group. Furthermore, no difference in QALYs was seen between the groups.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ACL</term><def><p id="Par5">Anterior cruciate ligament</p></def></def-item><def-item><term>CEAC</term><def><p id="Par6">Cost-effectiveness acceptability curve</p></def></def-item><def-item><term>CUA</term><def><p id="Par7">Cost-utility analysis</p></def></def-item><def-item><term>DB</term><def><p id="Par8">Double-bundle technique</p></def></def-item><def-item><term>DBG</term><def><p id="Par9">Double-bundle group</p></def></def-item><def-item><term>ICER</term><def><p id="Par10">Incremental cost-effectiveness ratio</p></def></def-item><def-item><term>KOOS</term><def><p id="Par11">Knee injury and osteoarthritis and outcome score</p></def></def-item><def-item><term>NE</term><def><p id="Par12">North-east</p></def></def-item><def-item><term>NW</term><def><p id="Par13">North-west</p></def></def-item><def-item><term>NSIB</term><def><p id="Par14">National social insurance board</p></def></def-item><def-item><term>OA</term><def><p id="Par15">Osteoarthritis</p></def></def-item><def-item><term>QALY</term><def><p id="Par16">Quality-adjusted life year</p></def></def-item><def-item><term>RCT</term><def><p id="Par17">Randomised clinical trial</p></def></def-item><def-item><term>ROM</term><def><p id="Par18">Range of motion</p></def></def-item><def-item><term>SB</term><def><p id="Par19">Single-bundle technique</p></def></def-item><def-item><term>SBG</term><def><p id="Par20">Single-bundle group</p></def></def-item><def-item><term>SD</term><def><p id="Par21">Standard deviation</p></def></def-item><def-item><term>SE</term><def><p id="Par22">South-east</p></def></def-item><def-item><term>SW</term><def><p id="Par23">South-west</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Mattias Molin, Statistiska Konsultgruppen, Gothenburg, Sweden.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>EH has made substantial contributions to conception and design and acquisition of data, analysis and interpretation of data, been involved in drafting the manuscript and revising it critically for important intellectual content. NS has made substantial contributions to conception and design and acquisition of data, analysis and interpretation of data, been involved in drafting the manuscript and revising it critically for important intellectual content.</p></notes><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p id="Par89">No conflicts of interest to declare.</p></sec><sec id="FPar2"><title>Funding</title><p id="Par890">The study was financially supported by the Swedish Research Council for Sport Science and the Healthcare sub-committee, Region V&#x000e4;stra G&#x000f6;taland.</p></sec><sec id="FPar3"><title>Ethical approval</title><p id="Par891">The study was approved by the Regional Ethical Committee at Gothenburg University (EPN Dnr 162-11) and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Participation in the Swedish national register is voluntary for surgeons and patients, and thus no written consent is necessary. All data are unidentifiable patient data.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahld&#x000e9;n</surname><given-names>M</given-names></name><name><surname>Sernert</surname><given-names>N</given-names></name><name><surname>Karlsson</surname><given-names>J</given-names></name><name><surname>Kartus</surname><given-names>J</given-names></name></person-group><article-title>A prospective randomized study comparing double- and single-bundle techniques for anterior cruciate ligament reconstruction</article-title><source>Am J Sports Med</source><year>2013</year><volume>11</volume><fpage>2484</fpage><lpage>2491</lpage><pub-id pub-id-type="doi">10.1177/0363546513497926</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archibald-Seiffer</surname><given-names>N</given-names></name><name><surname>Jacobs</surname><given-names>JC</given-names></name><name><surname>Saad</surname><given-names>C</given-names></name><name><surname>Jevsevar</surname><given-names>DS</given-names></name><name><surname>Shea</surname><given-names>KG</given-names></name></person-group><article-title>Review of anterior cruciate ligament reconstruction cost variance within a regional health care system</article-title><source>Am J Sports Med</source><year>2015</year><volume>43</volume><fpage>1408</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1177/0363546515579184</pub-id><pub-id pub-id-type="pmid">25899430</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardern</surname><given-names>CL</given-names></name><name><surname>Taylor</surname><given-names>NF</given-names></name><name><surname>Feller</surname><given-names>JA</given-names></name><name><surname>Webster</surname><given-names>KE</given-names></name></person-group><article-title>Fifty-five per cent return to competitive sport following anterior cruciate ligament reconstruction surgery: an updated systematic review and meta-analysis including aspects of physical functioning and contextual factors</article-title><source>Br J Sports Med</source><year>2014</year><volume>48</volume><fpage>1543</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2013-093398</pub-id><pub-id pub-id-type="pmid">25157180</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x000f6;rnsson</surname><given-names>H</given-names></name><name><surname>Andernord</surname><given-names>D</given-names></name><name><surname>Desai</surname><given-names>N</given-names></name><name><surname>Norrby</surname><given-names>O</given-names></name><name><surname>Forssblad</surname><given-names>M</given-names></name><name><surname>Petzold</surname><given-names>M</given-names></name><name><surname>Karlsson</surname><given-names>J</given-names></name><name><surname>Samuelsson</surname><given-names>K</given-names></name></person-group><article-title>No difference in revision rates between single- and double-bundle anterior cruciate ligament reconstruction: a comparative study of 16,791 patients from the Swedish national knee ligament register</article-title><source>Arthroscopy</source><year>2015</year><volume>31</volume><fpage>659</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2014.11.030</pub-id><pub-id pub-id-type="pmid">25618489</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonsell</surname><given-names>S</given-names></name></person-group><article-title>Financial analysis of anterior cruciate ligament reconstruction at Baylor University Medical Center</article-title><source>Proc (Bayl Univ Med Cent)</source><year>2000</year><volume>13</volume><fpage>327</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1080/08998280.2000.11927697</pub-id><pub-id pub-id-type="pmid">16389334</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazier</surname><given-names>JE</given-names></name><name><surname>Harper</surname><given-names>R</given-names></name><name><surname>Munro</surname><given-names>J</given-names></name><name><surname>Walters</surname><given-names>SJ</given-names></name><name><surname>Snaith</surname><given-names>ML</given-names></name></person-group><article-title>Generic and condition-specific outcome measures for people with osteoarthritis of the knee</article-title><source>Rheumatology (Oxford)</source><year>1999</year><volume>38</volume><fpage>870</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/38.9.870</pub-id><pub-id pub-id-type="pmid">10515649</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodtkorb</surname><given-names>T-H</given-names></name><name><surname>Henriksson</surname><given-names>M</given-names></name><name><surname>Johannesen-Munk</surname><given-names>K</given-names></name><name><surname>Thidell</surname><given-names>F</given-names></name></person-group><article-title>Cost-effectiveness of C-leg compared with non&#x02013;microprocessor-controlled knees: a modeling approach</article-title><source>Arch Phys Med Rehabil</source><year>2008</year><volume>89</volume><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2007.07.049</pub-id><pub-id pub-id-type="pmid">18164326</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>R</given-names></name></person-group><article-title>EuroQol: the current state of play</article-title><source>Health Policy</source><year>1996</year><volume>37</volume><fpage>53</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/0168-8510(96)00822-6</pub-id><pub-id pub-id-type="pmid">10158943</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brophy</surname><given-names>RH</given-names></name><name><surname>Wright</surname><given-names>RW</given-names></name><name><surname>Matava</surname><given-names>MJ</given-names></name></person-group><article-title>Cost analysis of converting from single-bundle to double-bundle anterior cruciate ligament reconstruction</article-title><source>Am J Sports Med</source><year>2009</year><volume>37</volume><fpage>683</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1177/0363546508328121</pub-id><pub-id pub-id-type="pmid">19204364</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coughlin</surname><given-names>MT</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name></person-group><article-title>Economic evaluation of new therapies in critical illness</article-title><source>Crit Care Med</source><year>2003</year><volume>31</volume><fpage>S7</fpage><pub-id pub-id-type="doi">10.1097/00003246-200301001-00002</pub-id><pub-id pub-id-type="pmid">12544971</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cournapeau</surname><given-names>J</given-names></name><name><surname>Klouche</surname><given-names>S</given-names></name><name><surname>Hardy</surname><given-names>P</given-names></name></person-group><article-title>Material costs of anterior cruciate ligament reconstruction with hamstring tendons by two different techniques</article-title><source>Orthop Traumatol Surg Res</source><year>2013</year><volume>2</volume><fpage>196</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.otsr.2012.10.013</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>P</given-names></name><name><surname>Gudex</surname><given-names>C</given-names></name><name><surname>Kind</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name></person-group><article-title>The time trade-off method: results from a general population study</article-title><source>Health Econ</source><year>1996</year><volume>5</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1050(199603)5:2&#x0003c;141::AID-HEC189&#x0003e;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">8733106</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>MF</given-names></name><name><surname>Sculpher</surname><given-names>MJ</given-names></name><name><surname>Torrance</surname><given-names>GW</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>BJ</given-names></name><name><surname>Stoddart</surname><given-names>GL</given-names></name></person-group><source>Methods for the economic evaluation of health care programmes</source><year>2005</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farshad</surname><given-names>M</given-names></name><name><surname>Gerber</surname><given-names>C</given-names></name><name><surname>Meyer</surname><given-names>DC</given-names></name><name><surname>Schwab</surname><given-names>A</given-names></name><name><surname>Blank</surname><given-names>PR</given-names></name><name><surname>Szucs</surname><given-names>T</given-names></name></person-group><article-title>Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis</article-title><source>BMC Health Serv Res</source><year>2011</year><volume>11</volume><fpage>317</fpage><pub-id pub-id-type="doi">10.1186/1472-6963-11-317</pub-id><pub-id pub-id-type="pmid">22098703</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenwick</surname><given-names>E</given-names></name><name><surname>Byford</surname><given-names>S</given-names></name></person-group><article-title>A guide to cost-effectiveness acceptability curves</article-title><source>Br J Psychiatry</source><year>2005</year><volume>187</volume><fpage>106</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1192/bjp.187.2.106</pub-id><pub-id pub-id-type="pmid">16055820</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Forssblad M (2014) Swedish ACL Register. In: Hospital, KU (Ed.) Annual Report 2014</mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Forssblad M (2015) Swedish ACL Register. In: Hospital, KU (Ed.) Annual Report 2015</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forssblad</surname><given-names>M</given-names></name><name><surname>Valentin</surname><given-names>A</given-names></name><name><surname>Engstrom</surname><given-names>B</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name></person-group><article-title>ACL reconstruction: patellar tendon versus hamstring grafts&#x02013;economical aspects</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2006</year><volume>14</volume><fpage>536</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1007/s00167-006-0064-3</pub-id><pub-id pub-id-type="pmid">16570193</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genuario</surname><given-names>JW</given-names></name><name><surname>Faucett</surname><given-names>SC</given-names></name><name><surname>Boublik</surname><given-names>M</given-names></name><name><surname>Schlegel</surname><given-names>TF</given-names></name></person-group><article-title>A cost-effectiveness analysis comparing 3 anterior cruciate ligament graft types: bone-patellar tendon-bone autograft, hamstring autograft, and allograft</article-title><source>Am J Sports Med</source><year>2012</year><volume>40</volume><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1177/0363546511426088</pub-id><pub-id pub-id-type="pmid">22085728</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>KS</given-names></name><name><surname>Nwachukwu</surname><given-names>BU</given-names></name><name><surname>Poehling</surname><given-names>GG</given-names></name></person-group><article-title>Lights, camera, action: how to make arthroscopy a star in value-based health care</article-title><source>Arthroscopy</source><year>2013</year><volume>29</volume><fpage>1900</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2013.10.001</pub-id><pub-id pub-id-type="pmid">24286792</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>EK</given-names></name><name><surname>Hansson</surname><given-names>TH</given-names></name></person-group><article-title>The costs for persons sick-listed more than 1 month because of low back or neck problems. A 2-year prospective study of Swedish patients</article-title><source>Eur Spine J</source><year>2005</year><volume>14</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1007/s00586-004-0731-3</pub-id><pub-id pub-id-type="pmid">15150703</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>M</given-names></name><name><surname>van Eck</surname><given-names>CF</given-names></name><name><surname>Cretnik</surname><given-names>A</given-names></name><name><surname>Dinevski</surname><given-names>D</given-names></name><name><surname>Fu</surname><given-names>FH</given-names></name></person-group><article-title>Prospective randomized clinical evaluation of conventional single-bundle, anatomic single-bundle, and anatomic double-bundle anterior cruciate ligament reconstruction: 281 cases with 3- to 5-year follow-up</article-title><source>Am J Sports Med</source><year>2012</year><volume>40</volume><fpage>512</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1177/0363546511426416</pub-id><pub-id pub-id-type="pmid">22085729</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;gglund</surname><given-names>M</given-names></name><name><surname>Wald&#x000e9;n</surname><given-names>M</given-names></name><name><surname>Thome&#x000e9;</surname><given-names>R</given-names></name></person-group><article-title>Should patients reach certain knee function benchmarks before anterior cruciate ligament reconstruction? Does intense &#x02018;prehabilitation&#x02019; before anterior cruciate ligament reconstruction influence outcome and return to sports?</article-title><source>Br J Sports Med</source><year>2015</year><volume>22</volume><fpage>1423</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2015-094791</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karikis</surname><given-names>I</given-names></name><name><surname>Ahlden</surname><given-names>M</given-names></name><name><surname>Casut</surname><given-names>A</given-names></name><name><surname>Sernert</surname><given-names>N</given-names></name><name><surname>Kartus</surname><given-names>J</given-names></name></person-group><article-title>Comparison of outcome after anatomic double-bundle and antero-medial portal non-anatomic single-bundle reconstruction in ACL-injured patients</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2016</year><volume>4</volume><fpage>1307</fpage><lpage>1315</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>J</given-names></name><name><surname>Becker</surname><given-names>R</given-names></name></person-group><article-title>Return to sports after ACL reconstruction: individual considerations</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2015</year><volume>23</volume><fpage>1271</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1007/s00167-015-3600-1</pub-id><pub-id pub-id-type="pmid">25869908</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiadaliri</surname><given-names>AA</given-names></name><name><surname>Englund</surname><given-names>M</given-names></name><name><surname>Lohmander</surname><given-names>LS</given-names></name><name><surname>Carlsson</surname><given-names>KS</given-names></name><name><surname>Frobell</surname><given-names>RB</given-names></name></person-group><article-title>No economic benefit of early knee reconstruction over optional delayed reconstruction for ACL tears: registry enriched randomised controlled trial data</article-title><source>Br J Sports Med</source><year>2016</year><volume>50</volume><fpage>558</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2015-095308</pub-id><pub-id pub-id-type="pmid">26935859</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>CP</given-names></name><name><surname>Song</surname><given-names>JQ</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name></person-group><article-title>Single-bundle versus double-bundle anterior cruciate ligament reconstruction: an up-to-date meta-analysis</article-title><source>Int Orthop</source><year>2013</year><volume>37</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1007/s00264-012-1651-1</pub-id><pub-id pub-id-type="pmid">22968440</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y-L</given-names></name><name><surname>Ning</surname><given-names>G-Z</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Q-L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>S-Q</given-names></name></person-group><article-title>Single-bundle or double-bundle for anterior cruciate ligament reconstruction: a meta-analysis</article-title><source>Knee</source><year>2014</year><volume>21</volume><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2012.12.004</pub-id><pub-id pub-id-type="pmid">23306028</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascarenhas</surname><given-names>R</given-names></name><name><surname>Cvetanovich</surname><given-names>GL</given-names></name><name><surname>Sayegh</surname><given-names>ET</given-names></name><name><surname>Verma</surname><given-names>NN</given-names></name><name><surname>Cole</surname><given-names>BJ</given-names></name><name><surname>Bush-Joseph</surname><given-names>C</given-names></name><name><surname>Bach</surname><given-names>BR</given-names></name></person-group><article-title>Does double-bundle anterior cruciate ligament reconstruction improve postoperative knee stability compared with single-bundle techniques? a systematic review of overlapping meta-analyses</article-title><source>Arthroscopy</source><year>2015</year><volume>6</volume><fpage>1185</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2014.11.014</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mather</surname><given-names>RC</given-names></name><name><surname>Koenig</surname><given-names>L</given-names></name><name><surname>Kocher</surname><given-names>MS</given-names></name><name><surname>Dall</surname><given-names>TM</given-names></name><name><surname>Gallo</surname><given-names>P</given-names></name><name><surname>Scott</surname><given-names>DJ</given-names></name><name><surname>Bach</surname><given-names>BR</given-names></name><name><surname>Spindler</surname><given-names>KP</given-names></name></person-group><article-title>Societal and economic impact of anterior cruciate ligament tears</article-title><source>J Bone Joint Surg Am</source><year>2013</year><volume>95</volume><fpage>1751</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.2106/JBJS.L.01705</pub-id><pub-id pub-id-type="pmid">24088967</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunez</surname><given-names>M</given-names></name><name><surname>Fernandez-Sola</surname><given-names>J</given-names></name><name><surname>Nunez</surname><given-names>E</given-names></name><name><surname>Fernandez-Huerta</surname><given-names>JM</given-names></name><name><surname>Godas-Sieso</surname><given-names>T</given-names></name><name><surname>Gomez-Gil</surname><given-names>E</given-names></name></person-group><article-title>Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1&#x000a0;year of follow-up</article-title><source>Clin Rheumatol</source><year>2011</year><volume>30</volume><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1007/s10067-010-1677-y</pub-id><pub-id pub-id-type="pmid">21234629</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nwachukwu</surname><given-names>BU</given-names></name><name><surname>Schairer</surname><given-names>WW</given-names></name><name><surname>Bernstein</surname><given-names>JL</given-names></name><name><surname>Dodwell</surname><given-names>ER</given-names></name><name><surname>Marx</surname><given-names>RG</given-names></name><name><surname>Allen</surname><given-names>AA</given-names></name></person-group><article-title>Cost-effectiveness analyses in orthopaedic sports medicine: a systematic review</article-title><source>Am J Sports Med</source><year>2014</year><volume>6</volume><fpage>1530</fpage><lpage>1537</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paxton</surname><given-names>ES</given-names></name><name><surname>Kymes</surname><given-names>SM</given-names></name><name><surname>Brophy</surname><given-names>RH</given-names></name></person-group><article-title>Cost-effectiveness of anterior cruciate ligament reconstruction: a preliminary comparison of single-bundle and double-bundle techniques</article-title><source>Am J Sports Med</source><year>2010</year><volume>38</volume><fpage>2417</fpage><lpage>2425</lpage><pub-id pub-id-type="doi">10.1177/0363546510375545</pub-id><pub-id pub-id-type="pmid">20829416</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabin</surname><given-names>R</given-names></name><name><surname>Charro</surname><given-names>Fd</given-names></name></person-group><article-title>EQ-SD: a measure of health status from the EuroQol Group</article-title><source>Ann Med</source><year>2001</year><volume>33</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.3109/07853890109002087</pub-id><pub-id pub-id-type="pmid">11491192</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltzman</surname><given-names>BM</given-names></name><name><surname>Cvetanovich</surname><given-names>GL</given-names></name><name><surname>Nwachukwu</surname><given-names>BU</given-names></name><name><surname>Mall</surname><given-names>NA</given-names></name><name><surname>Bush-Joseph</surname><given-names>CA</given-names></name><name><surname>Bach</surname><given-names>BR</given-names></name></person-group><article-title>Economic analyses in anterior cruciate ligament reconstruction: a qualitative and systematic review</article-title><source>Am J Sports Med</source><year>2015</year><volume>5</volume><fpage>1329</fpage><lpage>1335</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>M</given-names></name><name><surname>Karlsson</surname><given-names>J</given-names></name><name><surname>Ware</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group><article-title>The Swedish SF-36 health survey&#x02013;I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden</article-title><source>Soc Sci Med</source><year>1995</year><volume>41</volume><fpage>1349</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1016/0277-9536(95)00125-Q</pub-id><pub-id pub-id-type="pmid">8560302</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suomalainen</surname><given-names>P</given-names></name><name><surname>Kannus</surname><given-names>P</given-names></name><name><surname>Jarvela</surname><given-names>T</given-names></name></person-group><article-title>Double-bundle anterior cruciate ligament reconstruction: a review of literature</article-title><source>Int Orthop</source><year>2013</year><volume>37</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s00264-012-1680-9</pub-id><pub-id pub-id-type="pmid">23073927</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiamklang</surname><given-names>T</given-names></name><name><surname>Sumanont</surname><given-names>S</given-names></name><name><surname>Foocharoen</surname><given-names>T</given-names></name><name><surname>Laopaiboon</surname><given-names>M</given-names></name></person-group><article-title>Double-bundle versus single-bundle reconstruction for anterior cruciate ligament rupture in adults</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>11</volume><fpage>CD008413</fpage><pub-id pub-id-type="pmid">23152258</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname><given-names>SJ</given-names></name><name><surname>Brazier</surname><given-names>JE</given-names></name></person-group><article-title>Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D</article-title><source>Qual Life Res</source><year>2005</year><volume>14</volume><fpage>1523</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1007/s11136-004-7713-0</pub-id><pub-id pub-id-type="pmid">16110932</pub-id></element-citation></ref></ref-list></back></article>